Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis.

导出原文传递

翻译打印收藏纠错

第一作者： Brian M,Wei

第一单位： Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.

作者： Brian M,Wei ^[1] ; Lindy P,Fox ^[2] ; Benjamin H,Kaffenberger ^[3] ; Abraham M,Korman ^[3] ; Robert G,Micheletti ^[4] ; Arash,Mostaghimi ^[5] ; Megan H,Noe ^[5] ; Misha,Rosenbach ^[4] ; Kanade,Shinkai ^[2] ; Jason H,Kwah ^[6] ; Elizabeth J,Phillips ^[7] ; Jean L,Bolognia ^[1] ; William,Damsky ^[8] ; Caroline A,Nelson ^[9]

作者单位： Department of Dermatology, Yale School of Medicine, New Haven, Connecticut. ^[1] Department of Dermatology, University of California, San Francisco, California. ^[2] Department of Dermatology, The Ohio State University, Columbus, Ohio. ^[3] Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. ^[4] Department of Dermatology, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts. ^[5] Department of Medicine, Section of Rheumatology, Allergy and Immunology, Yale School of Medicine, New Haven, Connecticut. ^[6] Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. ^[7] Department of Dermatology, Yale School of Medicine, New Haven, Connecticut; Department of Pathology, Yale School of Medicine, New Haven, Connecticut. ^[8] Department of Dermatology, Yale School of Medicine, New Haven, Connecticut. Electronic address: Caroline.Nelson@yale.edu. ^[9]